[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: recombinant erythropoietin (r-EPO)in addition to standard care.: In 20 moderate to severely diseased patients who require ventilatory support(NIV/IV); 4000IU of r-EPO in addition to standard care would be administered subcutaneously on day 1; 2; 4 and 7th days.Control Intervention1: only standard care.: In 20 number of moderate to severely diseased patients only standard care treatment protocol will be followed.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: recombinant erythropoietin (r-EPO)in addition to standard care.: In 20 moderate to severely diseased patients who require ventilatory support(NIV/IV); 4000IU of r-EPO in addition to standard care would be administered subcutaneously on day 1; 2; 4 and 7th days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: only standard care.: In 20 number of moderate to severely diseased patients only standard care treatment protocol will be followed.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1076, "treatment_name": "Recombinant erythropoietin", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: recombinant erythropoietin (r-EPO)in addition to standard care.: In 20 moderate to severely diseased patients who require ventilatory support(NIV/IV); 4000IU of r-EPO in addition to standard care would be administered subcutaneously on day 1; 2; 4 and 7th days.Control Intervention1: only standard care.: In 20 number of moderate to severely diseased patients only standard care treatment protocol will be followed.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: recombinant erythropoietin (r-EPO)in addition to standard care.: In 20 moderate to severely diseased patients who require ventilatory support(NIV/IV); 4000IU of r-EPO in addition to standard care would be administered subcutaneously on day 1; 2; 4 and 7th days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: only standard care.: In 20 number of moderate to severely diseased patients only standard care treatment protocol will be followed.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]